Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000790818 | SCV000228393 | pathogenic | not provided | 2013-12-13 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000176696 | SCV000918010 | pathogenic | Autosomal recessive polycystic kidney disease | 2023-02-16 | criteria provided, single submitter | clinical testing | Variant summary: PKHD1 c.2725C>T (p.Arg909X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 251142 control chromosomes (gnomAD). c.2725C>T has been reported in the literature in individuals affected with Polycystic Kidney And Hepatic Disease (examples: Liang_2020, Obeidova_2020, Ajiri_2022,Ishiko_2022). These data indicate that the variant is likely to be associated with disease. Five clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and all laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. |
Invitae | RCV000176696 | SCV000937061 | pathogenic | Autosomal recessive polycystic kidney disease | 2024-01-19 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg909*) in the PKHD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PKHD1 are known to be pathogenic (PMID: 19940839). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PKHD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 167491). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000176696 | SCV001163053 | pathogenic | Autosomal recessive polycystic kidney disease | criteria provided, single submitter | clinical testing | ||
Revvity Omics, |
RCV001781495 | SCV002018818 | pathogenic | Polycystic kidney disease 4 | 2020-08-06 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV001781495 | SCV002060147 | pathogenic | Polycystic kidney disease 4 | 2021-11-10 | criteria provided, single submitter | clinical testing | NM_138694.3(PKHD1):c.2725C>T(R909*) is a nonsense variant classified as pathogenic in the context of autosomal recessive polycystic kidney disease, PKHD1-related. R909* has been observed in cases with relevant disease (PMID: 31730820, 32574212). Functional assessments of this variant are not available in the literature. R909* has not been observed in population frequency databases. In summary, NM_138694.3(PKHD1):c.2725C>T(R909*) is a nonsense variant in a gene where loss of function is a known mechanism of disease, is predicted to disrupt protein function, and has been observed more frequently in cases with the relevant disease than in healthy populations. Please note: this variant was assessed in the context of healthy population screening. |
Gene |
RCV000790818 | SCV002759201 | pathogenic | not provided | 2022-11-28 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 32574212, 31730820) |
Fulgent Genetics, |
RCV001781495 | SCV002811538 | pathogenic | Polycystic kidney disease 4 | 2021-10-08 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001781495 | SCV004204664 | pathogenic | Polycystic kidney disease 4 | 2023-05-08 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003917507 | SCV004728745 | pathogenic | PKHD1-related disorder | 2024-02-05 | criteria provided, single submitter | clinical testing | The PKHD1 c.2725C>T variant is predicted to result in premature protein termination (p.Arg909*). This variant has been reported to be pathogenic for autosomal recessive polycystic kidney disease (ARPKD) (Liang et al. 2019. PubMed ID: 31730820). This variant has not been reported in a large population database, indicating this variant is rare. Nonsense variants in PKHD1 are expected to be pathogenic. This variant is interpreted as pathogenic. |